Centene Corporation (CNC) Presents at Deutsche Bank 2026 Healthcare Summit Transcript

George Hill
Deutsche Bank AG, Research Division

Good morning, everybody, and welcome to the DB Healthcare Summit. I’m George Hill. I’m the Health Care Technology and Services Analyst at DB. I cover the MCOs and a bunch of the health care technology stuff. I call it the stuff. I’m very happy to have with us this morning Centene CEO, Sarah London; and CFO, Drew Asher. Good morning, guys.

Thanks for coming back. Sarah, you guys reiterated your 2026 guidance this morning of at least $4.80. I thought I would kick it to you to start. I guess just talk to us about the reiterated guidance. Any other introductory comments that you want to make? And then for Sarah, Drew, if there’s anything that you want to say as it relates to utilization or the moving pieces or if there’s anything different, would love to hear what you guys have to say to kick it off.

Sarah London
CEO & Director

Happy to provide a couple of updates on the quarter and then go deeper into any of it. Obviously, reiterated our full year adjusted diluted EPS guidance of greater than $4.80 this morning. I’m pleased with the trajectory of the business through 2 months of the quarter. We are in line with expectations. Trends that we’re seeing in Q3 broadly across lines of business consistent with trends that we saw in Q2.

Some of the highlights per business line. So Medicaid rates are coming in, in line with expectations and consistent with that 5% composite full year outlook for rates overall. In addition